DRREDDY had a strong weekly performance, returning 4.3% with a Sharpe Ratio of 1.36, indicating a favorable risk-return profile. The stock's volatility was relatively low at 12.35%, making it a less risky investment option. Compared to its peers, DRREDDY outperformed DIVISLAB and HINDUNILVR, but underperformed SUNPHARMA in terms of returns. Overall, the stock's performance was impressive, with a low max drawdown of 0.0%.

[Volatility: 12.35%]